Valeant's 'Moneyball' approach to dealmaking By: CNBC.com News September 08, 2015 at 10:00 AM EDT Is Valeant Pharmaceuticals CEO Mike Pearson the Billy Beane of pharma deals? Read More >> Related Stocks: Allergan Plc Amgen Astrazeneca Plc ADR Sentinelone Inc Cl A Synergetics Inc